Biotech Investment
WuXi Biologics, Fresenius partner ahead of biosimilar boom
By Anna Brown · 11/3/2026

WuXi Biologics and German drugmaker Fresenius have reached one of the largest biosimilar deals to date ahead of what some in the industry have called an upcoming “golden decade” for such products. ...
This is a preview. Read the complete article on Endpoints News.
Read the full article →